A study by Ouyang et al. showed that DCs in the tumor microenvironment could activate B cell differentiation toward the FcγRII low/IL-10 Breg phenotype, which could interrupt the initiation of cancer-induced immunosuppressive events [31]. The gene discussed is IL10; the disease is neoplasm.